Abstract
This report details the successful use of bilateral lung transplantation for the management of severe postoperative bleomycin-associated lung injury. This case highlights that the extremely favorable prognosis of advanced testicular germ cell tumors after systemic chemotherapy (>90% cure rate) should not preclude lung transplant consideration in all cases, despite current guidance that considers an advanced malignancy to be a contraindication for lung transplant listing. The Oncologist 2017;22:620-622.
© AlphaMed Press 2017.
MeSH terms
-
Adult
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Bleomycin / administration & dosage
-
Bleomycin / adverse effects*
-
Cisplatin / administration & dosage
-
Cisplatin / adverse effects
-
Etoposide / administration & dosage
-
Etoposide / adverse effects
-
Humans
-
Lung Injury / chemically induced
-
Lung Injury / diagnostic imaging
-
Lung Injury / pathology
-
Lung Injury / therapy*
-
Lung Transplantation*
-
Male
-
Neoplasms, Germ Cell and Embryonal / complications*
-
Neoplasms, Germ Cell and Embryonal / drug therapy
-
Neoplasms, Germ Cell and Embryonal / pathology
-
Testicular Neoplasms / complications*
-
Testicular Neoplasms / drug therapy
-
Testicular Neoplasms / pathology
Substances
-
Bleomycin
-
Etoposide
-
Cisplatin
Supplementary concepts
-
Testicular Germ Cell Tumor